3,5-Dibromobenzaldehyde

Catalog No.: 
ACTHEC140
CAS No.: 
56990-02-4
Molecular Formula: 
C7H4Br2O
Molecular Weight: 
263.92
3,5-Dibromobenzaldehyde structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100g98%$106.00In stockInquiry
500g98%$518.00In stockInquiry
1000g98%$881.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3,5-Dibromobenzaldehyde
IUPAC Name3,5-dibromobenzaldehyde
MDL No.MFCD00156887
Molecular FormulaC7H4Br2O
Molecular Weight263.92
SMILESO=CC1=CC(Br)=CC(Br)=C1
InChI KeyZLDMZIXUGCGKMB-UHFFFAOYSA-N
SynonymFT-0651963 | PS-7344 | Benzaldehyde, 3,5-dibromo- | SY014041 | FT-0614507 | D2832 | 3,5-bis(bromanyl)benzaldehyde | DTXSID80347485 | Z1269139271 | AM20040736 | J-511268 | (3,5-dibromo-phenyl)-methanone | CS-W001128 | SCHEMBL708554 | 3,5-Dibromobenzaldehyd
CAS No.56990-02-4
PubChem CID622077

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P301+P312-P302+P352-P304+P340-P305+P351+P338

Synthetic Route by SureRoute

1. ACTHEC140 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCNYP638 route compound structure diagram
    ACCNYP638626-39-1In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTHEC140 route product structure diagram
    ACTHEC14056990-02-4In Stock
Inquiry

2. ACTHEC140 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACPMSY607 route compound structure diagram
    ACPMSY607145691-59-4In Stock
  2. Then
  3. ACTHEC140 route product structure diagram
    ACTHEC14056990-02-4In Stock
Inquiry

3. ACTHEC140 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTHEC140 route product structure diagram
    ACTHEC14056990-02-4In Stock
Inquiry

Comments (0)